Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol KDM4B contributors: mct - updated : 23-12-2020
HGNC name lysine (K)-specific demethylase 4B
HGNC id 29136
Corresponding disease
GDDLM global developmental delay (GDD) with language and motor skills defects
Location 19p13.3      Physical location : 4.969.123 - 5.153.606
Synonym name
  • jumonji domain containing 2B
  • jmjC domain-containing histone demethylation protein 3B
  • Synonym symbol(s) KIAA0876, JHDM3B, FLJ44906, JMJD2B, TDRD14B
    EC.number 1.14.11.66
    DNA
    TYPE functioning gene
    STRUCTURE 184.52 kb     23 Exon(s)
    regulatory sequence Promoter
    Binding site   transcription factor
    text structure GATA-binding sites within intron 6
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    23 - 5675 121.8 1096 - 2020 32034099
    12 - 3077 - 448 - 2020 32034099
    11 - 2907 - 429 - 2020 32034099
    EXPRESSION
    Type
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Nervousbrainlimbic systemhippocampus highly Mus musculus
     brain   highly Mus musculusFetal
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    physiological period embryo
    Text differentiated and undifferentiated stem cells
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • two jumonji catalytic demethylase domains, one is the N-terminal portion (JmjN) and one is the C-terminal portion (JmjC) domain
  • a double tudor domain
  • and two plant homeodomains (PHDs)
  • conserved dual PHD and Tudor domains in addition to its JmjC domains
  • HOMOLOGY
    interspecies homolog to murine Jmjd2b
    Homologene
    FAMILY
  • JMJD2 family
  • JHDM3 histone demethylase family
  • KDM4 histone demethylase subfamily
  • CATEGORY regulatory , DNA associated
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • generates different methylated states at the same lysine residue provides a mechanism for fine-tuning histone methylation
  • demethylate histone lysine and arginine residues in an oxidative reaction that requires Fe(II) and alpha-ketoglutarate as cofactors
  • involved in regulation of transcription, DNA-dependent
  • demethylate H3K9me3 at pericentric heterochromatin in mammalian cells
  • demethylation of H3K9me3 in round spermatids is dispensable for spermatogenesis but possible defects in KDM4D-null elongating spermatids could be rescued by functional redundancy of the KDM4B demethylase
  • essential role in the estrogen signaling
  • KDM4A, KDM4B, KDM4C, catalyze demethylation of tri- and di-methylated forms of both histone H3 lysine 9 (H3K9me3/me2) and lysine 36 (H3K36me3/me2)
  • expression of KDM4B is itself regulated in a hypoxia-inducible factor- and hypoxia-dependent manner, suggesting multiple ways in which oxygen levels regulate histone methylation
  • histone demethylase that regulates chromatin structure or gene expression by removing methyl residues from trimethylated lysine 9 on histone H3
  • required for sustained proliferation and survival of tumor cells, and its aberrant expression may contribute to the pathogenesis of gastric cancer
  • KDM4B and KDM6B promotes osteogenic differentiation of mesenchymal stem/stromal cells (MSCs)
  • KDM4Bis a DNA damage response (DDR) protein and overexpression of KDM4B may contribute to the failure of anti-cancer therapy that relies on the induction of DNA damage
  • role for KDM4B in mitochondrial apoptosis
  • regulatory effect exerted by KDM4B on tumor growth through the modulation of TP53 target genes
  • histone demethylase KDM4B promotes tumorigenesis by inducing retrotransposition and DNA damage
  • can function as a signal responsive trans-acting splicing factor and scaffold that recruits and stabilizes the spliceosome near the alternative exon, thus promoting its inclusion
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • integral component of the H3K4-specific methyltransferase, the mixed-lineage leukemia (MLL) 2 complex
  • constitutes a key component of the estrogen signaling pathway
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • recruited to ESR1 target sites, demethylates H3K9me3 and facilitates transcription of ER responsive genes including MYB, MYC and CCND1
  • physically associated with and an integral component of the H3K4 methyltransferase MLL2 complex
  • novel feed forward mechanism involving CEBPB and KDM4B in the regulation of mitotic clonal expansion by controlling cell cycle gene expression
  • KDM4B enzymatic activity is required to enhance AR transcriptional activity
  • HSP90AA1 interacts and stabilizes KDM4B protein
  • KDM4B plays key roles in myogenic differentiation of C2C12 cells, presumably by its function as a H3-K9 specific histone demethylase
  • MYCN was found to physically interact with and recruit KDM4B
  • KDM4B play a critical role during inner ear invagination via modulating histone methylation of the direct target DLX3
  • HAX1 is required for KDM4B-mediated mitochondrial apoptosis
  • TP53 directly regulates KDM4B gene expression by binding to a canonical TP53-consensus motif in the KDM4B promoter
  • lysine-specific demethylase with a preferential activity on H3K9 tri/di-methylation (H3K9me3/2)-modified histones
  • cell & other
    REGULATION
    induced by hypoxia and HIF (induce transcription of the JMJD1A and JMJD2B genes leading to increased protein expression)
    Other transcriptionally regulated by ESR1
    regulated by both ESR1 and HIF1A
    ASSOCIATED DISORDERS
    corresponding disease(s) GDDLM
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in renal cancer cells that have lost the von Hippel Lindau tumor suppressor protein VHL and therefore display a deregulated expression of hypoxia-inducible factor
    tumoral     --over  
    in colorectal cancer (CRC) tissues
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerreproductiveprostate
    is a viable therapeutic target in Prostate carcinoma
    cancerreproductivebreast
    potential therapeutic target in breast cancer
    cancerreproductiveprostate
    KDM4B may be served as a potential target for Castration-resistant prostate cancer (CRPC) therapy
    cancerdigestivecolon
    potential therapeutic cancer target in Colorectal cancer (
    osteoarticularboneostéoporosis
    KDM4B may present as therapeutic targets for controlling mesenchymal stem/stromal cells (MSCs) fate choices and lead to clues for new treatment in metabolic bone diseases such as osteoporosis
    ANIMAL & CELL MODELS